Company news
OPKO Health, Inc. news in 2019
OPKO Health, Inc.'s news releases, calls and decks from 2019, newest first.
OPKO Health to Present at the 38th Annual J.P. Morgan Healthcare Conference
December 18, 2019
OPKO Health to Participate in the 31st Annual Piper Jaffray Healthcare Conference
November 25, 2019
Novitas Issues Final Local Coverage Determination for the 4Kscore® Test
November 14, 2019
OPKO Health Reports 2019 Third Quarter Business Highlights and Financial Results
November 4, 2019
OPKO Health to Report Third Quarter 2019 Financial Results on November 5, 2019
October 31, 2019
OPKO Health, Inc. Announces Pricing of its Offering of Common Stock
October 23, 2019
OPKO Health, Inc. Announces Proposed Offering of Common Stock
October 21, 2019
OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
October 20, 2019
BioReference Laboratories Recognized by Forbes as Best Large Employer of 2019
April 16, 2019
OPKO Reports Additional Oxyntomodulin, OPK-88003, Results From Phase 2 Diabetes and Obesity Trial
April 11, 2019